Jeffrey Schwartz, MD

New data suggest adding fibrate therapy to frontline PBC treatment could result in earlier and higher rates of biochemical response.

Analysis from a multicenter, randomized, double-blind, parallel group study comparing the drugs as induction and maintenance therapies in biologic-naïve patients.